Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1705–1728 of 2,516 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Apoplexy Clear all

Conditions: Stroke, Shoulder Pain
Interventions: Peripheral Nerve Stimulation, Physical Therapy, Sham-PT, Sham-PNS; Device · Other
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: 21 Years to 89 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 3
States / cities: Chicago, Illinois • Charlotte, North Carolina • Cleveland, Ohio

Conditions: Myocardial Infarction, Stroke
Interventions: Mass Media plus clinic intervention., Media; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 45 Years to 75 Years
Enrollment: 10,800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Cerebrovascular Stroke, Upper Extremity Paresis
Interventions: Paired Vagus Nerve Stimulation, Rehabilitation; Device · Other
Lead sponsor: MicroTransponder Inc.; Industry
Eligibility: 22 Years to 80 Years
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 15
States / cities: Scottsdale, Arizona • Downey, California • Santa Monica, California + 12 more

Conditions: Multiple Sclerosis, Stroke
Interventions: Movement to Music, Adapted Yoga; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 65 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Stroke, Stroke, Acute, Stroke, Ischemic
Interventions: Frequent PT, Intense PT; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 80 Years
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Stroke, Upper Extremity Paresis, Hemiplegia
Interventions: Active conventional tDCS montage plus CCFES, Active unconventional tDCS montage plus CCFES, Sham tDCS plus CCFES, CCFES with Occupational Therapy; Device · Behavioral
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: 21 Years to 90 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Stroke, Acute Ischemic, Hypertension
Interventions: Social Network Group Counseling, Individual Counseling; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Ischemic Stroke
Interventions: TF0023; Drug
Lead sponsor: Techfields Inc; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 24
States / cities: Scottsdale, Arizona • Colorado Springs, Colorado • Englewood, Colorado + 19 more

Conditions: Stroke, Acute
Interventions: Minocycline; Drug
Lead sponsor: David Hess, MD; Other
Eligibility: 19 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 2
States / cities: Lexington, Kentucky • Portland, Oregon

Conditions: Stroke
Interventions: lovastatin; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: New York, New York

Conditions: Stroke
Interventions: Aggrenox, Clopidogrel placebo, Micardis, Aggrenox placebo, Clopidogrel, Micardis placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 50 Years and older
Enrollment: 20,332 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 204
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 160 more

Conditions: Stroke
Interventions: Not listed
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years and older
Enrollment: 2,005 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 8
States / cities: Washington D.C., District of Columbia • New York, New York

Conditions: Stroke, Hypertension
Interventions: Home BP Telemonitoring (HBPTM), Nurse Case Management (NCM); Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Cardiovascular Disease, Stroke
Interventions: Personalized Heart Attack and Stroke Risk, Standard Education; Other
Lead sponsor: Durham VA Medical Center; Federal
Eligibility: 55 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Aphasia
Interventions: Script Training; Behavioral
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 21 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: MELAS Syndrome
Interventions: Dichloroacetate; Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 6 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2000
U.S. locations: 1
States / cities: New York, New York

Conditions: Stroke
Interventions: Full-pressure ECP, Sham-pressure ECP; Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 85 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 3
States / cities: Birmingham, Alabama • Los Angeles, California • San Diego, California

Conditions: Prevention & Control
Interventions: Rivaroxaban (Xarelto, BAY59-7939), Aspirin, Aspirin placebo, Rivaroxaban placebo, Pantoprazole, Pantoprazole placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 27,395 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2021
U.S. locations: 53
States / cities: Birmingham, Alabama • Mobile, Alabama • Anaheim, California + 49 more

Conditions: Preterm Less Than 32wks With IVH, WMI/PVL, Late Preterm or Term (37-42wks) With Neonatal Encephalopathy Treated With Hypothermia for HIE
Interventions: Prospective Clinical and Neurodevelopmental Data Collection; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 31 Weeks to 42 Weeks
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Coronary Heart Disease, Stroke, Diabetes, Breast Cancer, Ovarian Cancer, Colorectal Cancer
Interventions: Familial risk assessment and personalized prevention messages; Behavioral
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 35 Years to 65 Years
Enrollment: 8,400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 3
States / cities: Evanston, Illinois • Leawood, Kansas • Ann Arbor, Michigan

Conditions: Ischemic Stroke
Interventions: Privigen, Normal Saline; Biological · Other
Lead sponsor: Inova Health Care Services; Other
Eligibility: 45 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Falls Church, Virginia

Conditions: Stroke, Hemispatial Neglect
Interventions: tDCS, sham tDCS, Repetitive task-specific practice (RTP); Device · Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Chronic Stroke, Hemiplegia, Hemiparesis, Paralysis
Interventions: Real-time action observation with augmented Kinect; Device
Lead sponsor: University of Michigan; Other
Eligibility: 40 Years to 80 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Canton, Michigan

Conditions: Stroke
Interventions: Transcranial magnetic stimulation (TMS); Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Search by objective public record fields.

Multimodal Treatment for Hemiplegic Shoulder Pain

Testing a Community Intervention to Increase Aspirin Use

Pivotal Study of VNS During Rehab After Stroke (VNS-REHAB)

Lakeshore Examination of Activity and Disability Exercise Response Study

Frequency vs Error Augmentation Training in Acute Physical Therapy Post Stroke

tDCS + CCFES-mediated Functional Task Practice for Post-stroke Upper Extremity Hemiplegia

TEAMS-BP (The Enhancement of Social Networks to Augment Management of Stroke-Blood Pressure)

A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes

Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke

Neuroprotection With Statin Therapy for Acute Recovery Trial (Neu-START)

PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes

Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities

Practice-Based Trial of Home BP Telemonitoring Among Minority Stroke Survivors

The Effectiveness of Personalized Stroke Risk Communication

Modulating Intensity and Dosage of Aphasia Scripts

Evaluating the Effectiveness of a Dichloroacetate in MELAS Syndrome

Safety Study of External Counterpulsation as a Treatment for Acute Ischemic Stroke

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease

Cerebral/ Cortical Visual Impairment: Screening, Identification and Outcome Prediction in Neonates

Evaluating Tools for Health Promotion and Disease Prevention

IVIG in Acute Ischemic Stroke: A Pilot Study

Transcranial Direct Current Stimulation (tDCS) and Task-Specific Practice for Post-stroke Neglect

Implementing Technology Enhanced Real Time Action Observation Therapy in Persons With Chronic Stroke

Phase-dependent Evaluation of Motor Cortex Excitability With TMS in Stroke